Upstream Bio, Inc. (UPB)
2.74
-0.25
(-8.36%)
USD |
NASDAQ |
Oct 23, 16:00
2.735
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Price to Book Value : 0.5539 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.5539 |
| October 22, 2026 | 0.6044 |
| October 21, 2026 | 0.566 |
| October 20, 2026 | 0.57 |
| October 19, 2026 | 0.566 |
| October 16, 2026 | 0.5579 |
| October 15, 2026 | 0.6812 |
| October 14, 2026 | 0.6913 |
| October 13, 2026 | 0.7176 |
| October 12, 2026 | 0.8429 |
| October 09, 2026 | 0.9501 |
| October 08, 2026 | 0.9197 |
| October 07, 2026 | 0.9319 |
| October 06, 2026 | 0.9278 |
| October 05, 2026 | 0.9804 |
| October 02, 2026 | 1.019 |
| October 01, 2026 | 1.019 |
| September 30, 2026 | 1.065 |
| September 29, 2026 | 1.049 |
| September 28, 2026 | 1.071 |
| September 25, 2026 | 1.084 |
| September 24, 2026 | 1.045 |
| September 23, 2026 | 1.049 |
| September 22, 2026 | 1.110 |
| September 21, 2026 | 1.084 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.079 |
| September 17, 2026 | 1.073 |
| September 16, 2026 | 1.077 |
| September 15, 2026 | 1.108 |
| September 14, 2026 | 1.174 |
| September 11, 2026 | 1.158 |
| September 10, 2026 | 1.162 |
| September 09, 2026 | 1.205 |
| September 08, 2026 | 1.251 |
| September 04, 2026 | 1.215 |
| September 03, 2026 | 1.229 |
| September 02, 2026 | 1.310 |
| September 01, 2026 | 1.324 |
| August 31, 2026 | 1.338 |
| August 28, 2026 | 1.352 |
| August 27, 2026 | 1.372 |
| August 26, 2026 | 1.441 |
| August 25, 2026 | 1.451 |
| August 24, 2026 | 1.336 |
| August 21, 2026 | 1.409 |
| August 20, 2026 | 1.385 |
| August 19, 2026 | 1.519 |
| August 18, 2026 | 1.385 |
| August 17, 2026 | 1.443 |
| August 14, 2026 | 1.429 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sutro Biopharma, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
Price to Book Value Related Metrics
| PS Ratio | 47.08 |
| PEG Ratio | -0.0233 |
| Price | 2.74 |
| Earnings Yield | -105.3% |
| Market Cap | 150.07M |
| PEGY Ratio | -0.0233 |